Trial intelligence / Profile preview

Lidocaine spray for pain relief during endometrial sampling

TCTR20250210001Phase 4Completed

Sponsor
Phrae Hospital
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of lidocaine in menstrual disorders (2 arms), sponsored by Phrae Hospital. Primary endpoint: Pain score during procedure. Started Oct 2023; status: completed.

02

Drugs

lidocaine
03

Conditions

menstrual disorders

Beyond the preview

Go deeper on TCTR20250210001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250210001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call